| Ytd | -56.66% | |
| 1y | -74.37% |
| Open | 6.72 | Prev Close | 6.82 | Low | 6.72 | High | 6.79 | Mkt Cap | 214.14M |
| Vol | 350.00 | Avg Vol | 239.17K | EPS | -3.37 | P/E | -2.02 | Forward P/E | N/A |
| Beta | -0.32 | Short Ratio | 1.15 | Inst. Own | 18.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 7.92 | 200-d Avg | 16.04 | 1yr Est | 0.00 |
SUPX News
On August 6, 2026, the Company's board of directors authorized a share repurchase program under
SINGAPORE, Aug. 7, 2026 /PRNewswire/ -- SuperX AI Technology Limited (Nasdaq: SUPX, the "Company" or
On June 25, 2026, SuperX AI Technology Limited (the "Company") entered into two material cor
SuperX AI Technology Limited (NASDAQ:SUPX), a NASDAQ-listed full-stack AI infrastructure solutions p
SuperX AI Technology Limited (NASDAQ:SUPX, ", SuperX", or the ", Company", ))), an e
SuperX AI Technology Limited ("SuperX" or the "Company"), a full-stack AI infrastruc
SuperX AI Technology Limited (NASDAQ:SUPX) ("SuperX" or the "Company"), an emerging
Stocks fall, Nasdaq drops 200 points. Apogee Therapeutics (APGE) rises 19.4% on positive trial data.
SuperX AI Technology Limited (NASDAQ:SUPX, ", SuperX", or the ", Company", ))), toda
Leveraging Modular Architecture to Accelerate Japan's AI Infrastructure Development.OSAKA, Japan
SuperX AI Technology Limited (NASDAQ:SUPX) ("the Company" or "SuperX") today announc
SuperX AI Technology Limited (NASDAQ:SUPX) ("SuperX" or "the Company"), a full-stack
SuperX AI Technology Limited (NASDAQ:SUPX) ("the Company" or "SuperX"), a provider o
The Singapore-based joint venture, majority-controlled by SuperX, is established to provide end-to-e
